Bitcoin

Bitcoin
Bitcoin

Evening digest: tech rally cools, Kraken spins out, Bitcoin flashes warning signs

Markets are closing the year with a shift in tone. Tonight’s digest tracks a cooling tech rally, a landmark energy-tech spinoff, and volatility across hard assets and crypto. From profit-taking in mega-cap stocks to silver’s violent reversal and Bitcoin flashing technical warning signs, the common thread is transition. As calendar-driven momentum fades and 2026 approaches,

Read More
Bitcoin

David Beckham’s Prenetics halts $1B Bitcoin plan to focus on IM8 health brand

Prenetics Global, a health sciences company backed and co-founded by football superstar David Beckham, has rolled back its ambitious Bitcoin accumulation strategy just months after kicking off efforts to stockpile the flagship cryptocurrency. According to a Dec. 30 statement from the company, Prenetics has stopped all purchasing activity since Dec. 4 and has no plans

Read More
Bitcoin

US spot Bitcoin ETFs break the seven-day outflow streak with $355M inflows

US spot Bitcoin exchange‑traded funds (ETFs) rebounded sharply on Tuesday, registering a combined $355 million in net inflows and ending a seven‑day sequence of outflows that reflected subdued investor activity as the year drew to a close. Data from Coinglass shows that the resurgence in capital occurred across multiple major products, with BlackRock’s iShares Bitcoin

Read More
Bitcoin

Bitwise expands product suite with 11 single-asset strategy ETFs

Bitwise has filed with the United States Securities and Exchange Commission to launch 11 new exchange-traded funds that would track a range of individual altcoins while also investing in related financial products. Per the Dec. 31 filing, Bitwise’s new “strategy” funds would give investors exposure to a wide array of tokens such as Aave, Starknet’s

Read More
Bitcoin

Evening digest: Nvidia China surge, Trump crypto push, Bitcoin breakout watch

Markets are looking to kick off the year with a volatile mix of tech, geopolitics, speculative finance, and protectionism. Nvidia is racing to meet surging Chinese demand for its H200 AI chips amid shifting export politics, while Trump Media leans into crypto with a controversial shareholder token. India tightens trade defenses to shield steel inputs,

Read More
Bitcoin

Why CryptoQuant believes Bitcoin has been in a bear market for 2 months

Bitcoin may already be several weeks into a bear market, according to CryptoQuant’s head of research, even as many analysts continue to forecast strong growth for the cryptocurrency in 2026. Speaking on an episode of the Milk Road show on Thursday, CryptoQuant’s Julio Moreno said that most of the indicators he tracks through the firm’s

Read More
Bitcoin

Crypto market rally today: here’s why Bitcoin and altcoins are going up

The crypto market rally resumed today, Jan. 2, as investors bought the recent dip. Bitcoin price rose to over $88,500, while Ethereum jumped by $3,000. The market capitalization of all tokens jumped by 1.35% to over $3 trillion. Most altcoins were in the green, with Story (IP) rising by 30%. Pepe token jumped by 25%,

Read More
Bitcoin

A major challenge CFTC faces in regulating prediction markets in 2026

Prediction markets gained immense popularity in 2025 – moving well beyond commodities and into elections, sports, and even central bank appointments. Once niche hedging tools, they now attract mainstream attention and billions in trading volume. Former CFTC enforcement director Ian McGinley told CNBC that “prediction markets have existed for decades,” but their rapid expansion this

Read More
Bitcoin

AMD stock sees unusual options activity as whale calls dominate

Big investors placed a flurry of options bets on Advanced Micro Devices (NASDAQ: AMD stock), according to Benzinga’s options scanner, which flagged 32 unusual trades. Calls outnumbered puts, and the largest tickets targeted a wide range of strikes from $140.0 to $280.0 over the last three months. The trading activity occurs because AMD’s stock price

Read More
Bitcoin

Why Corcept Therapeutics stock crashed today and what comes next?

Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant, its candidate treatment for Cushing’s syndrome. The setback cast doubt on CORT’s pipeline strength and triggered a sharp re-evaluation by analysts. It underscores the market’s sensitivity to regulatory developments in small-cap drug makers.

Read More